| Papers [1-14] of 100 :: [Page 1 of 8] | | Go to page : 1 2 3 4 5 6 7 8 —> | Search results on "MULTIPLE SCLEROSIS QUALITY LIFE": |
|
|
Multiple Sclerosis and Quality of Life, 2008.
This paper discusses that certain symptoms of multiple sclerosis (MS) that lead to higher levels of disability, fatigue and depression will result in lower quality of life for MS patients.
2,487 words (approx. 9.9 pages), 4 sources, MLA, £ 52.95
»
Click here to show/hide summary
Abstract
In this article the writer discusses the nature of the relationship between disability, depression, fatigue and quality of life for people with multiple sclerosis. The writer notes that the focus of the research is to get a clearer understanding of the primary as well as secondary factors that affect people with multiple sclerosis. The writer also notes that, as stated by Benito-Leon et al, there exist many other factors that affect sufferers of multiple sclerosis, besides the impairment or rehabilitative nature of the disease.
Outline:
Scope of Study
Literature Review
Hypotheses
Method
Participants & Materials
Procedure
Results
Descriptive Statistics
Pearson Product Moment Correlation
Discussion
Findings
Study Limitations
From the Paper
" MS research has not been focused on understanding the QOL among MS patients. Few studies have focused on the how the symptoms of MS affect noted measures of QOL. The general understanding is that as a whole MS seems to lower QOL; however few studies have been able to provide the necessary link between QOL, and specific aspects of MS related symptoms. Nortvedt and Riise completed a literature review and found that the literature was either validating the use of measurement criterions, focusing on the factors that influence QOL within MS patients, or focusing on using lift questionnaires to understand the impacts of MS. Many of the studies examined used similar measurement via quality of life questionnaires and clinical scales to identify the nature of the relationship between QOL and MS."
| |
|
Multiple Sclerosis, 2006.
A critical analysis of the coercion between multiple sclerosis, depression, and the adolescent psyche.
2,817 words (approx. 11.3 pages), 9 sources, APA, £ 57.95
»
Click here to show/hide summary
Abstract
The paper discusses and draws conclusions of the coercion between multiple sclerosis, depression, and the adolescent psyche.
The paper is written as follows:
INTRODUCTORY PHASE
History of Multiple Sclerosis - Historical Origins, facts, and progressive timeline of MS.
Description & Characteristics of Multiple Sclerosis -Detailed description of MS; causes and symptoms.
Description & Characteristics of Depression - Detailed description of Depression; causes and symptoms.
ESSENTIAL PHASE
Multiple Sclerosis, Depression, & Adolescence - Overview of two schools of thought towards the relationship between MS and adolescent depression.
Psychological Effect - Detailed description, with examples of the Psychological Effect's school of thought as it pertains to adolescents diagnosed with both MS and clinical depression.
Treatment - Summary of the primary treatment used today for adolescent depression with MS.
Future of Depressed Adolescents with MS - Quick glimpse into recent progressions made in MS research.
From the Paper
" Afflicting people of all ages, and of all walks of life, Multiple Sclerosis (commonly referred to as MS) is a disease of the central nervous system and is prevalent in all nations across the globe. In spite of the fact that anybody can develop MS, the disease is predominantly found in adolescents, and most especially in female adolescents. Approximately 2,500,000 people around the world are diagnosed with MS. In the United States of America alone, statistics show that one in every seven hundred people has multiple sclerosis (Rose & Mackay, 1998). With roots tracing as far back as the middle ages, MS was amongst the first diseases to be accurately assessed through the use of the scientific method, which was derived in the early nineteenth century. In 1868 Jean-Martin Charcot, a professor of neurology at the University of Paris, who has been called "the father of neurology", carefully examined a young woman with a tremor of a sort he had never seen before. He was the first to document the disease of Multiple Sclerosis, and record its multitude of characteristics (Britannica, 2006). Fifty years the latter of Charcot's achievements, a detailed microscopic description made by James Dawson revealed the basic damage done in MS, and helped bring forth the biggest happening within the disease's historical timeline; the creation of the National Multiple Sclerosis Society in 1946 by Sylvia Lawry (MSAA, 2004). With respect to the creation of the National Multiple Sclerosis Society, the last sixty years have been characterized by breakthroughs in diagnosing, treating, and preventing MS. In response to an international outcry for support, governments around the world, as well as medical societies, research companies, and donation services have joined forces in pursuing the ultimate goal of curing Multiple Sclerosis."
| |
|
Multiple Sclerosis: Disease and Treatment, 2006.
This paper cites and details various articles relating to the treatment of multiple sclerosis (MS).
3,529 words (approx. 14.1 pages), 12 sources, APA, £ 68.95
»
Click here to show/hide summary
Abstract
This paper defines multiple sclerosis (MS) as a common neurological disorder responsible for substantial neurological morbidity. MS is an autoimmune disease that attacks the central nervous system, the spine and the brain. This paper evaluates and analyzes various published medical articles and research studies related to the treatment of MS. This paper discusses the use of interferon-beta-1a also known as Avonex, for the treatment of MS. The company that manufactures Avonex notes that while MS is an unpredictable disease in regards to symptoms, using Avonex as a once-a-week therapy can help slow the progression of disability in relapsing forms of MS. This paper contains case study results of patients with MS who used Avonex as well as other treatments and therapies.
Table of Contents:
What is Intramuscular Interferon Beta 1a Therapy?
Multiple Sclerosis and its Treatments
What is Avonex?
MS Footnotes
Bibliography
From the Paper
"Despite the setback experienced by Avonex and patient's preference for Comaxone, treatment of multiple sclerosis has come a long way. Before the investigation into interferons, physicians were only able to treat some of their MS patients with Prednisone or other immunosuppressives. The problem with Prednisone or Methotrexate (a drug used to treat cancer and also used to repress rejection of transplanted organs) were first they were not that effective and second they had long term side effects which included osteoporosis and high cholesterol for Prednisone and the possibility of catching an infection and dying with Methotrexate."
| |
|
Aquatic Therapy for Multiple Sclerosis Patients, 2002.
Reviews literature on Aquatic Therapy and its general effects on patients with Multiple Sclerosis (MS) in order to evaluate the effectiveness of this form of rehabilitation for MS patients.
6,747 words (approx. 27.0 pages), 29 sources, APA, £ 106.95
»
Click here to show/hide summary
Abstract
This paper examines the nature of Multiple Sclerosis. It discusses its symptoms, probable causes, diagnosis and treatment. The paper then evaluates the effectiveness of a rehabilitative technique said to be useful to a variety of patients with chronic illnesses including those patients with multiple sclerosis. In particular, the study evaluates the effects of Aquatic Therapy for improving the functionality of MS patients. The primary method used to develop this evaluation is that of a literature search on the subject.
From the Paper
"Because MS is a neurological disorder, other pertinent literature regarding the benefits of aquatic therapy consists of studies indicating that the rehabilitation strategy has worked for patients with general neurologic disorders. In this regard, Morris (1997) discusses several benefits that have been for Aquatic Therapy with patients with neurologic disorders. The benefits listed by Morris include: profound relaxation, greater stretching of muscles resulting in increased flexibility, increased muscular strength, increased ability of the patient to stabilize multiple segments of the body, improved skill in specific patterns of movement, and increases in postural stability during functional activities."
| |
|
Multiple Sclerosis, 2006.
An in-depth study and analysis of multiple sclerosis, causes, effects and possible solutions.
4,230 words (approx. 16.9 pages), 5 sources, MLA, £ 77.95
»
Click here to show/hide summary
Abstract
In this paper the author analyzes in full the potential causes, effects and possible solutions that there are to multiple sclerosis. Amongst other things, he looks at the disease as a genetic auto immune disease and examines how diet can help. The author also mentions many of the preventative treatments that have been tried and are used and some of the research surrounding these. The paper concludes with the positive note that research is continuous in this field to try and help those that suffer from multiple sclerosis.
From the Paper
"The basic pathogenesis of MS involves the entry of immune cells (e.g. T cells, B cells, macrophages) into the CNS through the walls of the capillaries and venules. Immune reactions occur, a lesion is formed and myelin is eventually destroyed. Myelin consists of fatty tissue which wraps around nerve axons. It essentially acts as nerve insulation and is critical for proper nerve transmissions. Loss of myelin results in degradation of nerve transmissions and a resultant multitude of disabilities which gradually worsen over time as more myelin is destroyed."
| |
|
Multiple Sclerosis or MS, 2002.
Discussion of some of the theories about why people contract Multiple Sclerosis.
650 words (approx. 2.6 pages), 3 sources, £ 18.95
»
Click here to show/hide summary
Abstract
Multiple Sclerosis is an illness that over 350,000 people in the United States have. There is no specific cause. However, there are several theories about why people have Multiple Sclerosis. Ninety percent of MS patients diagnosed are between the ages of 16 and 60, but MS can be diagnosed as early as childhood or even after age 60.
| |
|
Multiple Sclerosis, 2008.
A brief overview of the physiology, classification and treatment of multiple sclerosis.
1,065 words (approx. 4.3 pages), 5 sources, APA, £ 25.95
»
Click here to show/hide summary
Abstract
This paper examines how multiple sclerosis is an autoimmune disease in which the immune system malfunctions and targets and destroys the myelin and oligodendrocyte cells of the brain and spinal cord. It looks at how the disease also causes irreparable damage in the central nervous system (CNS) by destroying targeted axons. It also discusses how treatment of the disease includes the treatment of acute symptoms and treatments to reduce the frequency of the relapse of the disease.
From the Paper
"The pathology of MS involves inflammation of the targeted area, demyelination of the axon and axon degeneration. Axon degeneration permanently destroys the demyelinated axon and causes irreversible damage to the CNS. This damage is responsible for the persistent disabling features of the disease. The CNS performs as a distributed network of activities. MS attacks individual parts of the CNS causing varied degrees of disabilities in specific domains of neurological function. Therefore, no two MS patients are affected in exactly the same way. MS is usually first diagnosed between 15 and 50 years of age (Randall, & Schapiro 2003). "
| |
|
Multiple Sclerosis, 2007.
Examines the effects of multiple sclerosis.
1,456 words (approx. 5.8 pages), 7 sources, MLA, £ 33.95
»
Click here to show/hide summary
Abstract
As a disease, multiple sclerosis affects more than 300,000 people in the United States with females being diagnosed with MS more than males. This paper examines the symptoms and effects of the disease and examines some of the different treatment methods used by sufferers.
From the Paper
"Regardless of how successful any type of treatment for multiple sclerosis may turn out to be, living with the disease can be extremely challenging for not only the affected person but also for families and friends. Even people who are disabled by MS to a moderate degree will discover that almost every aspect of life, whether walking, working, eating, sleeping or participating in physical activities for exercise, will be affected. This is especially true if the afflicted person is a parent or is married, for under such conditions, entire households may need to be completely rearranged for the convenience of the person with MS (Kraft 178)."
| |
|
Multiple Sclerosis, 2002.
Describes disease, Multiple Sclerosis, the current treatment for the disease, and the needs of MS patients.
1,400 words (approx. 5.6 pages), 4 sources, £ 36.95
»
Click here to show/hide summary
Abstract
Multiple Sclerosis, or MS, is a chronic and disabling disease that affects one out of every ten-thousand people, is most common among those of Northern European ancestry, and typically appears between the ages of twenty to thirty. MS is a progressive neurological disorder that affects the functions of the physical structures and systems of the body with symptoms ranging from numbness and lowered motor control of the limbs to paralysis and blindness. It is the purpose of this paper to examine the specific needs of patients with MS, the description of the disease, treatment, and the projected outcome.
| |
|
Multiple Sclerosis, 2004.
An extensive analysis of Multiple Sclerosis and current treatment modalities.
2,361 words (approx. 9.4 pages), 4 sources, MLA, £ 50.95
»
Click here to show/hide summary
Abstract
This paper identifies the development of Multiple Sclerosis (MS), examining possible causes and diagnosis techniques. The paper examines the progression of disease and presents current treatment modalities and research studies currently in progress. The paper explains that while the causes of MS are still being studied, there may be evidence of genetic predisposition, environmental factors, viruses and autoimmune dysfunction. The paper contends that research so far is inconclusive and researchers think MS develops due to a combination of these factors. Diagnostic studies are reviewed and discussed as to diagnosing the disease. The progression of the disease is discussed from relapsing-remitting MS to progressive MS. The paper presents a discussion of current treatment modalities based on the symptoms and type of MS that is diagnosed. The paper also examines the current clinical trials in progress and approval of new treatment modalities. The paper looks at several treatments, with the main focus on a research of a new drug therapy with monoclonal-antibodies called Tysabri.
Outline
Abstract
Introduction
Types of MS
Possible Causes
Diagnostic Methods
Treatment Modalities
Research
Conclusion
From the Paper
"MS is a chronic, long term condition that affects the central nervous system, including the brain and spinal cord. MS is thought to be related to immune dysfunction, where the body's immune system attacks itself called an autoimmune disease. Studies show that the development of MS may occur as genetic predisposition. For example, if a family member has MS one would have a slightly higher incidence of developing the disease. It is not thought to occur by genetics alone, but in relation to an environmental exposure or infection. Factors that have been linked to development of the disease are the above mentioned genetic factor, environmental factors, viruses, and autoimmune disease. Environmental factors show a decrease in the incidence of the disease the closer to the equator that one lives. Studies have shown a higher incidence in northern states with seasonal changes, than in southern states. Researchers have not been able to identify the exact chromosome that would indicate MS. "
| |
|
Multiple Sclerosis, 2002.
An insight into the condition of the multiple sclerosis, a disease of the central nervous system.
1,552 words (approx. 6.2 pages), 8 sources, MLA, £ 34.95
»
Click here to show/hide summary
Abstract
This paper looks at multiple sclerosis (MS), a disease of the central nervous system in which the myelin, which normally insulates nerve fibers and helps conduction of impulses, is damaged in random areas. It examines the different symptoms of MS which include feelings of weakness, clumsiness or exhaustion at the beginning followed by double vision, weakness of the arms and legs, muscle stiffness, dizziness, loss of bladder control, depression and memory loss. It evaluates the current myths and misconceptions about the disease such that it is fatal and everyone with MS ends up in a wheelchair. It describes the current courses of treatment and how the MS patient must learn to accept the changes in their life brought about by the disease, such as changes in work capabilities and changes in lifestyle.
From the Paper
"As the disease progresses, symptoms may become more severe and may leave lasting disabilities between actual episodes, so the MS patient will have to make adjustments to their life as the disease develops. This may mean changing jobs or working hours, making adjustments in the workplace and home to cater to a wheelchair or other assistive devices, changes in lifestyle such as taking a nap frequently when the patient gets tired easily, limiting travel and having help in the home. The MS patient has to make many adjustments to cope with the changes in their capabilities brought about by MS, but they can still lead full, rewarding lives, and still work. If they are one of the lucky ones who have long periods of remission between episodes, they may be able to function normally for long periods of time, and just learn to make the necessary adjustments during episodes of MS flare-up."
| |
|
Multiple Sclerosis: Not Everyone Who Falls Down is a Klutz, 2001.
This paper gives an overview of the symptoms and causes of multiple sclerosis. It includes illustrations of myelin sheathe damage, author's personal experiences with MS, and in-depth descriptions of three drugs commonly used to treat MS.
1,540 words (approx. 6.2 pages), 3 sources, MLA, £ 34.95
»
Click here to show/hide summary
Abstract
This is a concise paper explaining the symptoms of MS as well as the difficulty involved with diagnosing the disease. It explains the cases for some accepted potential causes and also examines the different types of MS. The three drugs used most commonly to treat MS - Avonex, Copaxone, and Beta-Seron - are compared and contrasted, and the pros and cons are duly noted. Paper written by an MS sufferer who also details her own experiences with the disease.
From the Paper
"In normal human beings, the immune system will spot and attack threats to the human body, like viruses or harmful bacteria. In a person with MS, the immune system sees myelin as one of these threats. Immune system cells come into the central nervous system and start attacking the myelin sheath, creating an autoimmune response - when the human body attacks itself. On these demyelinated areas, lesions known as "plaque" develop. The plaques eventually turn into scar tissue, sclerosis, in many different locations, which is where the name "multiple sclerosis" comes from. Thus, people with MS are more or less walking around with scars on their nerves."
| |
|
Multiple Sclerosis, 2005.
An overview of this disease that affects the nervous system.
7,100 words (approx. 28.4 pages), 34 sources, MLA, £ 109.95
»
Click here to show/hide summary
Abstract
Multiple sclerosis is one of the most common diseases of the nervous system, afflicting people of virtually all ages around the world, although it has a special preference for young people, especially women, and for those who grew up in northern latitudes. This paper examines the history of MS and provides an in-depth study of the advances that have been made in finding a treatment for multiple sclerosis.
The History of MS
The Discovery of MS
Effective Treatment: A Prisoner Of Biotechnology
An Unexpected Breakthrough
A Promising Start
A Worldwide Research Effort Begins
A New Major Partner
New Research Directions
Multiple Sclerosis and its Newest Treatments
Avonex: A New Wonder Drug?
From the Paper
"Interferon-beta-1a is better known as Avonex. The Drug Company that manufactures this treatment notes that multiple sclerosis (MS) is an unpredictable disease. On some days, you may have such problems as blurred vision, tingling hands, or loss of balance. On other days, there may be no symptoms at all, but the fear of permanent disability is always in the back of your mind. The manufacturer tells us that the good news is that now MS patients can do something to help maintain their current level of functioning. AVONEX? is a once-a-week therapy that can help slow the progression of disability in relapsing forms of MS."
| |
|
The Effects of Multiple Sclerosis, 2007.
Examines this disease's effects on an individual's family and friends.
1,800 words (approx. 7.2 pages), 7 sources, MLA, £ 39.95
»
Click here to show/hide summary
Abstract
In her memoir "Waist-High in the World", author Nancy Mairs writes candidly about how having multiple sclerosis (MS) had impacted her self-image, body image, and day to-day activities and life overall. This paper shows that Mairs's detailed reflections on dealing with multiple sclerosis (MS) shed light on the myriad physical, psychological, emotional, and other challenges that typically fill the lives of those with MS. This paper discusses the disease and how it most typically impacts its victims, as well as their families and friends.
From the Paper
"However, not all cases are equal (in fact none are): in symptoms; progression, or severity. One person's MS symptoms and disabilities from the disease, will most often be entirely different from those of someone else. Moreover, even if someone develops severe physical limitations as a result of the disease, these may not and often do not show up until the disease has progressed for a considerable time - perhaps 25 to 30 years after diagnosis."
|
|
|
